Patents Assigned to Advantagene, Inc.
  • METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS
    Publication number: 20190216903
    Abstract: A method is disclosed for decreasing or retarding an increase in the size of a localized or metastatic tumor by using a combination of an immune stimulating cytotoxic gene therapy and immune-checkpoint modulating agent, in conjunction with other therapies, including radiation therapy, chemotherapy, surgery, and immunotherapies.
    Type: Application
    Filed: March 27, 2019
    Publication date: July 18, 2019
    Applicant: ADVANTAGENE, INC.
    Inventor: Estuardo Aguilar-Cordova
  • Methods of cytotoxic gene therapy to treat tumors
    Patent number: 10350275
    Abstract: A method is disclosed for decreasing or retarding an increase in the size of a localized or metastatic tumor by using a combination of an immune stimulating cytotoxic gene therapy and immune-checkpoint modulating agent, in conjunction with other therapies, including radiation therapy, chemotherapy, surgery, and immunotherapies.
    Type: Grant
    Filed: September 19, 2014
    Date of Patent: July 16, 2019
    Assignee: Advantagene, Inc.
    Inventor: Carlos Estuardo Aguilar-Cordova